Injection sclerotherapy (n=77) | Octreotide (n=73) | |
Age (years) (median (range)) | 52 (30–83) | 57 (36–83) |
M/F | 38/39 | 47/27 |
Type of bleed | ||
Index bleed (first variceal bleed) | 29 | 421-150 |
Interval bleeds (second or subsequent variceal bleed) | 48 | 31 |
Child’s grade | ||
A | 11 | 12 |
B | 25 | 22 |
C | 41 | 39 |
Cause of portal hypertension | ||
Intrahepatic | ||
Alcohol | 50 | 46 |
CAH | 3 | 4 |
Cryptogenic | 6 | 7 |
Haemochromatosis | 0 | 2 |
Hepatitis B and C | 0 | 1 |
Sclerosing cholangitis | 6 | 3 |
PBC | 9 | 6 |
Sarcoidosis | 0 | 1 |
Unkown | 2 | 3 |
Extrahepatic | ||
PVT | 1 | 0 |
CAH, chronic active hepatitis; PBC, primary biliary cirrhosis; PVT, portal vein thrombosis.
↵1-150 p<0.05.